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Class I obesity is paradoxically associated
with decreased risk of postoperative stroke
after carotid endarterectomy
Rubie Sue Jackson, MD, MPH,a,b James H. Black III, MD,a Ying Wei Lum, MD,a
Eric B. Schneider, PhD,c Julie A. Freischlag, MD,a Bruce A. Perler, MD,a and
Christopher J. Abularrage, MD,a Baltimore, Md; and Washington, DC
Introduction: Although obesity is a risk factor for vascular disease, previous studies have shown an obesity paradox with
decreased mortality in obese patients undergoing vascular surgery. This study examined the relationship between body
mass index (BMI) and outcomes after carotid endarterectomy (CEA).
Methods: The 2005-2009 American College of Surgeons National Surgical Quality Improvement Program database was
queried to evaluate 30-day outcomes after isolated CEA across National Institutes of Health-defined obesity classes. 2
analysis was used to assess the unadjusted relationship of BMI category to postoperative outcomes. The independent
association of BMI with morbidity and mortality was assessed with multivariable logistic regression, adjusting for
preoperative and operative characteristics.
Results: In the cohort of 23,652 CEA, 1.8% of patients were underweight (BMI <18.5), 26.6% were normal weight (BMI
18.5-24.9), 39.4% were overweight (BMI 25.0-29.9), 21.1% were class I obese (BMI 30.0-34.9), 7.5% were class II obese
(BMI 35.0-39.9), and 3.5% were class III obese (BMI >40). The overall stroke and mortality rates were 1.4% and 0.6%,
respectively. On univariable analysis, there wereU-shaped relationships between death (P .017) and stroke (P .029), with
the lowest incidence in overweight and class I obese patients. The incidence of surgical site infection (SSI) (P .021) increased
incrementally with increasing BMI. On multivariable analysis, class I obesity was the only variable associated with decreased
risk of stroke (odds ratio [OR], 0.51; 95% confidence interval [CI], 0.31-0.83; P .007). Independent risk factors for stroke
were previous transient ischemic attack (OR, 1.97; P  .006), American Society of Anesthesiologists class 4 to 5 (OR, 1.62;
P  .010), surgery performed by a nonvascular surgeon (OR, 1.85; P  .015), and hemiplegia (OR, 1.97; P  .018). There
was also a trend, althoughnot statistically significant, toward decreasedmortality risk associatedwith class I obesity (OR, 0.53;
95%CI, .26-1.08; P .080). Class II obesity was associated with an increased risk of SSI compared with normal weight (OR,
2.21; 95% CI, 1.01-4.82; P  .047). BMI category was not associated with the risk of myocardial infarction.
Conclusions: An obesity paradox exists for stroke and mortality after CEA; for stroke, but not mortality, this protective
association was independent of patient demographics and comorbidities. Obesity is not a contraindication to CEA, and
surgeons may safely undertake CEA in obese patients when indicated. (J Vasc Surg 2012;55:1306-12.)
o
v
m
t
g
s
a
p
d
p
a
t
t
a
c
o
N
MObesity has reached epidemic proportions in much of
the developed world, with approximately 35% of United
States citizens classified as overweight and 30% classified as
obese.1 Obesity is an established risk factor for cardiovascular
disease, including coronary disease, coronary death, conges-
tive heart failure, and ischemic stroke,2,3 and accounts for as
many as 7% to 13% of deaths in developed countries.4,5
Despite the well-established health risks associated with
obesity, some research has pointed to the existence of an
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1306besity paradox in surgery, with improved postoperative sur-
ival for overweight and obese patients, compared with nor-
al-weight patients.6-10 A study of general surgery patients in
he 2005-2006 American College of Surgeons National Sur-
ical Quality Improvement Program (ACS NSQIP) database
howed that overweight and class II obese patients had lower
djusted 30-day mortality risk compared with normal-weight
atients.6 Similarly, several large retrospective studies of car-
iac and vascular surgery patients have demonstrated im-
roved 30-day7,8 or long-term9,10 survival in overweight
nd/or obese patients compared with normal-weight pa-
ients. However, these studies have not distinguished among
he various vascular surgery procedures. In particular, the
ssociation of body mass index (BMI) with outcomes after
arotid endarterectomy (CEA) is not well understood.
The purpose of this study was to examine the association
f obesity with 30-day outcomes after CEA in the ACS
SQIP database.
ETHODS
The Johns Hopkins Medicine Institutional Review
oard approved this study.
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Volume 55, Number 5 Jackson et al 1307Study cohort. This is a retrospective analysis of pro-
spectively collected data in the ACS NSQIP database. The
ACS NSQIP provides risk-adjusted surgical outcomes data
to private sector surgical service administrators for the
purposes of quality assessment and improvement. At each
participating hospital, trained nurse reviewers prospectively
collect preoperative, operative, and postoperative data from
patients undergoing major surgical procedures, according
to a uniform protocol.11
CEA procedures in the ACS NSQIP from 2005 to
2009 were included. CEA was defined by a combination of
current procedural technology (CPT) code (35301 or
35390) and International Classification of Diseases, Ninth
Edition (ICD-9) code (433.1, 433.10, 433.11, 433.30, or
433.31) (Table I). Any procedure for which height and/or
weight information was not recorded, as well as CEAs
performed with simultaneous coronary artery bypass graft
(CABG; CPT 33510, 33511, 33512, 33513, 33514,
Table I. CPT and ICD-9 codes used to define study coho
CPT codes
35,301 Thromboendarterectomy, including patch
35,390 Reoperation, carotid, thromboendarterec
ICD-9 codes
433.1 Occlusion and stenosis of precerebral arte
433.10 Occlusion and stenosis of precerebral arte
433.11 Occlusion and stenosis of precerebral arte
433.30 Occlusion and stenosis of precerebral arte
433.31 Occlusion and stenosis of precerebral arte
CPT, Current procedural technology; ICD-9, International Classification o
Table II. Patient demographics, behaviors, operative char
across BMI categories
Underweight
(n  428)
Normal weight
(n  6301)
Demographics
Female, % 63.1 46.4
Black, % 5.1 4.0
Age, mean (years) 73.3 73.0
Behaviors
Current smoker, % 52.8 33.6
Current ethanol abuse, % 5.8 4.7
Operative characteristics
Emergency, % 1.6 0.9
ASA class, %
1-2 9.3 10.5
3 74.3 78.4
4-5 16.4 11.0
General anesthesia, % 84.6 83.2
Vascular surgeon, % 94.9 95.1
Laboratory values
Platelets 150,000/mL, % 5.9 7.7
White blood cells 11,000
cells/mL, %
7.1 6.9
Blood urea nitrogen 40
mg/dL, %
3.8 3.8
Hematocrit 45%, % 8.7 8.2
ASA, American Society of Anesthesiology; BMI, body mass index.33515, 33516, 33517, 33518, 33519, 33521, 33522, t3523, 33530, 33533, 33534, 33535, 33536, 33542, or
3545) were excluded. Patients with ascites were also ex-
luded, since BMI would be expected not to correlate with
diposity in these patients.
Outcomes. Primary outcomes were death and stroke.
econdary outcomes were operative reintervention, myo-
ardial infarction (MI), cardiac arrest, and surgical site
nfection (SSI). SSI was defined as superficial or deep SSI,
rgan/space SSI, or wound dehiscence. All other outcomes
ere predefined NSQIP binary outcome variables.
Adjustment variables. BMI was defined, using pre-
perative weight and height measurements, as weight
kg)/height (m2), and was categorized as underweight
BMI 18.5 kg/m2), normal weight (18.5-24.9 kg/m2),
verweight (25.0-29.9 kg/m2), class I obese (30.0-34.9
g/m2), class II obese (35.0-39.9 kg/m2), or class III
bese (40.0 kg/m2).12
ACS NSQIP preoperative and operative characteris-
t, if performed; carotid, vertebral, or subclavian, by neck incision
, more than 1 month after original operation
arotid artery
arotid artery, without mention of cerebral infarction
arotid artery, with mention of cerebral infarction
ultiple and bilateral, without mention of cerebral infarction
ultiple and bilateral, with mention of cerebral infarction
ases, Ninth Edition.
istics, and preoperative laboratory values, compared
weight
9322)
Class I obese
(n  4997)
Class II obese
(n  1773)
Class III obese
(n  831)
P
value
.8 38.9 48.7 61.1 .001
.5 3.7 6.2 4.5 .001
.6 69.8 68.1 66.1 .001
.8 23.2 21.2 25.4 .001
.7 4.0 1.9 2.4 .001
.4 1.1 0.9 1.1 .124
.001
.3 8.6 7.0 3.9
.8 79.2 79.5 77.7
.9 12.2 13.5 18.4
.0 83.6 85.4 86.6 .023
.4 94.1 95.3 95.0 .026
.4 7.7 7.0 6.3 .481
.8 7.0 6.6 9.3 .001
.3 4.4 4.9 7.2 .001
.0 12.3 10.8 7.8 .001rt
graf
tomy
ries: c
ries: c
ries: c
ries: m
ries: macter
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(n 
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May 20121308 Jackson et alII and III. The ACS NSQIP defines current smoking as
smokingwithin 1 year prior to surgery. Current ethanol abuse
is defined as consumption of two or more drinks daily during
the 2 weeks preceding surgery. Diabetes and hypertension are
defined by use of medication to treat these conditions.13
Statistical analysis. Analysis of variance was used to
compare means of continuous variables across BMI catego-
ries. The 2 statistic was used to compare binary and
categorical baseline characteristics and unadjusted inci-
dence proportions across BMI categories. Multivariable
logistic regression was used to assess the adjusted associa-
tion of BMI category with each study outcome. All baseline
characteristics were considered, and backwards stepwise
regression, using an exit criterion of P  .1, was used to
select variables for final model inclusion. BMI categories
and baseline characteristics that were significantly associ-
ated with BMI category (Tables II and III) were forced into
Table III. Patient preoperative comorbidities, compared a
Underweight
(n  428)
Normal weight
(n  6301)
Transient ischemic attack, % 21.1 26.3
Stroke without residual
neurological deficit, %
8.9 8.6
Stroke with residual neurological
deficit, %
16.6 13.3
Hemiplegia, % 7.9 5.3
Central nervous system tumor, % 0 0.1
Myocardial infarction, % 1.4 1.3
Previous percutaneous coronary
intervention, %
14.5 15.3
Previous cardiac surgery, % 14.3 20.2
Angina, % 3.0 1.8
Treated hypertension, % 79.7 81.9
Congestive heart failure, % 1.2 0.7
Previous surgery for peripheral
vascular disease, %
13.1 11.0
Ventilator, % 0 0.1
Chronic obstructive pulmonary
disease, %
22.2 11.0
Pneumonia, % 0.5 0.2
Dyspnea, % with exercise at rest 19.6 15.7
1.4 1.2
Acute renal failure, % 0 0.2
Dialysis, % 1.4 1.2
Esophageal varices, % 0 0.1
Treated diabetes, %
Oral medication 7.2 12.6
Insulin 3.5 4.6
Disseminated cancer, % 0.2 0.3
Preoperative open/infected
wound, %
2.6 1.5
Steroid use, % 2.6 2.4
Weight loss, % 3.7 1.0
Systemic inflammatory response
syndrome/sepsis, %
1.6 0.6
Dependent, %
Partially 9.8 5.0
Totally 0.5 0.4
BMI, Body mass index.
P values for the 2 statistic are displayed.the models. To assess multicollinearity, weighted regres- tion was used to calculate variance inflation factors (VIFs)
nd tolerances. Multicollinearity was defined as VIF 2 or
olerance 0.50, and model reduction was attempted for
ny variable showing evidence of multicollinearity. P values
.05 were considered statistically significant.
ESULTS
During the study period, 24,002 CEA procedures were
dentified. After excluding 322 procedures for unrecorded
eight and/or weight, 17 procedures for simultaneous
ABG, and 11 procedures for ascites, 23,652 procedures
ere included in the analysis. Of these, 1.8% were under-
eight, 26.6% were normal weight, 39.4% were over-
eight, 21.1% were class I obese, 7.5% were class II obese,
nd 3.5% were class III obese.
Baseline characteristics are displayed in Tables II and
II. The majority of underweight and class III obese pa-
s BMI categories
erweight
9322)
Class I obese
(n  4997)
Class II obese
(n  1773)
Class III obese
(n  831)
P
value
27.6 27.2 26.1 26.6 .173
8.5 8.4 8.8 7.7 .950
12.3 12.5 11.6 13.7 .030
4.3 4.5 3.6 3.5 .001
0.1 0.1 0 0 .376
1.5 1.4 1.5 1.4 .924
18.8 20.9 22.9 24.1 .001
24.4 25.9 27.0 21.8 .001
2.2 2.6 4.3 3.6 .001
85.2 88.4 89.4 90.6 .001
0.6 1.1 1.2 1.2 .003
8.6 9.2 9.0 8.7 .001
0.1 0 0 0 .746
8.9 9.9 10.9 13.0 .001
0.1 0.1 0 0.1 .013
15.5 20.6 25.8 31.7 .001
1.0 1.1 1.6 1.8
0.2 0.3 0.2 0.4 .631
0.8 0.9 0.7 0.7 .161
0.1 0.1 0 0 .792
17.8 23.4 26.3 28.6 .001
6.9 12.6 20.4 24.6
0.2 0.2 0 0 .200
1.1 1.2 1.2 2.1 .011
2.0 1.8 1.4 1.6 .057
0.3 0.3 0.3 0.2 .001
0.4 0.7 1.3 0.7 .001
3.4 3.3 4.7 4.8 .001
0.2 0.3 0.2 0.1cros
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Volume 55, Number 5 Jackson et al 1309BMI categories were male. Overall, 3.9% of patients were
black, with the lowest proportion of black patients in the
overweight and class I obese categories. History of tran-
sient ischemic attack and stroke without residual neurolog-
ical deficit were similar across BMI categories. History of
stroke with residual neurological deficit, American Society
of Anesthesiologists class 4-5, congestive heart failure,
chronic obstructive pulmonary disease, dyspnea, preopera-
tive open/infected wound, and dependent functional sta-
tus each had “U”-shaped distributions, with the highest
prevalence in the underweight and class III obese cate-
gories. History of percutaneous coronary intervention,
treated hypertension, and diabetes increased with in-
creasing BMI category. Mean age and the prevalence of
current smoking, current ethanol abuse, hemiplegia, and
history of surgery for peripheral vascular disease decreased
with increasing BMI category. A history of cardiac surgery
was most common among classes I and II obese patients.
Weight loss was most common among underweight pa-
ce
, %
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Fig. Incidence (95% confidence interval [CI]) of mor
infection (D) by bodymass index (BMI) category. P value
BMI categories, are shown.tients. pThe overall mortality rate was 0.6%. Postoperative
troke occurred in 1.4%, operative reintervention in 4.8%,
ardiac arrest in 0.3%, MI in 0.6%, and SSI in 0.6% of cases.
n unadjusted analysis, the incidences of death (P .017),
troke (P .029), and SSI (P .021) differed significantly
cross BMI categories, and there was a nonsignificant trend
oward an association between BMI category and cardiac
rrest (P  .053; Fig). Death and stroke had U-shaped
istributions, with the highest incidence in the extremes of
eight and the lowest incidence in overweight and class I
bese patients. In contrast, the incidence of SSI and cardiac
rrest increased incrementally with increasing BMI cate-
ory.
On multivariable analysis (Tables IV and V), class I
besity was associated with a 50% reduction in the risk of
troke (P  .007), compared with normal weight. Ameri-
an Society of Anesthesiologists class 4-5 (P  .010),
urgery performed by a nonvascular surgeon (P  .015),
revious transient ischemic attack (P  .006), and hemi-
e,
 %
C 350.0=P
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(A), stroke (B), cardiac arrest (C), and surgical site
the 2 statistic, testing for a difference in incidence acrosstality
s forlegia (P  .018) were each significantly associated with
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May 20121310 Jackson et alincreased risk of stroke. Class I obesity was also associated
with a nonsignificant trend toward decreased risk of mor-
tality (P  .080).
In contrast, class II obesity was associated with a two-
fold increase in the risk of SSI (P  .047), and class III
obesity was also associated with a strong trend toward
increased risk of SSI (P  .055), compared with normal
weight. Increasing age was associated with decreasing risk
of SSI (P  .010).
Class III obesity was also associated with a trend toward
increased risk of cardiac arrest (P  .104), compared with
normal weight. BMI was not significantly associated with
operative reintervention or MI on univariable or multivari-
able analysis.
DISCUSSION
Although obesity is a risk factor for development of
cerebrovascular disease,3 the present study found evidence
of a paradoxical reduction in the risk of stroke and death
among class I obese patients after CEA. Compared with
normal-weight patients, class I obese patients had a signif-
Table IV. Multivariable analysis of primary outcomes
Death OR
(95% CI)
Stroke OR
(95% CI)
BMI category
Underweight 0.31 (0.04-2.43) 1.37 (0.61-3.07)
Normal weight Reference Reference
Overweight 0.78 (0.46-1.30) 0.90 (0.63-1.27)
Class I obese 0.53 (0.26-1.08) 0.51 (0.31-0.83)a
Class II obese 0.95 (0.41-2.23) 1.28 (0.75-2.19)
Class III obese 1.65 (0.67-4.10) 1.16 (0.57-2.35)
Age, 5-year increase 1.18 (1.03-1.35)b
American Society of
Anesthesiologists
class
3 Reference Reference
4-5 2.14 (1.32-3.46)a 1.62 (1.12-2.35)b
Nonvascular surgeon 1.85 (1.12-2.35)b
Blood urea nitrogen
40 mg/dL
2.60 (1.34-5.03)a
Transient ischemic
attack
1.51 (1.13-2.03)a
Hemiplegia 1.97 (1.12-3.45)b
Previous myocardial
infarction
3.27 (1.37-7.81)a
Previous surgery for
peripheral vascular
disease
1.78 (1.02-3.09)b
Chronic obstructive
pulmonary disease
2.22 (1.31-3.75)a
Dyspnea at rest 2.98 (1.19-7.43)b
Disseminated cancer 8.28 (1.75-39.28)a
Partially dependent
status
2.91 (1.63-5.20)c
BMI, Body mass index; CI, confidence interval; OR, odds ratio.
OR (95%CI) associated with BMI categories and with statistically significant
variables included in the final model.
aP  .01.
bP  .05.
cP  .001.icantly reduced risk of stroke on both univariable and aultivariable analysis. Class I obese patients had a signifi-
antly reduced risk of death on univariable analysis, with a
rend toward decreased risk of death on multivariable anal-
sis. In contrast, class II obesity was associated with an
ncrease in the risk of SSI, and class III obesity had a
rend-level association with increased risk of cardiac arrest
ompared with normal weight.
Although several reports have demonstrated an obesity
aradox for perioperative mortality,6-10 to the authors’
nowledge, the present finding of an obesity paradox for
erioperative stroke has not been reported previously.
owever, Vemmos and colleagues recently reported an
nalogous finding from a large prospective cohort study of
atients hospitalized after a first stroke.14 The authors
ound that obesity and overweight were associated with
educed short-term (1-week) and long-term (10-year)
ortality. Furthermore, obese patients were less likely than
ormal-weight or overweight patients to die during the
cute poststroke phase from severe neurological damage, or
o die subsequently from recurrent strokes. These data
uggest a possible neuroprotective effect of obesity in pa-
ients having sustained a cerebrovascular insult, a result
nalogous to the present study’s finding of decreased risk of
ost-CEA stroke in class I obese patients.
The U-shaped relationship between BMI and postopera-
ive mortality parallels, and is probably attributable to, the
-shaped relationship between BMI and postoperative
troke. The fact that the protective relationship between class
obesity andmortality did not reach statistical significance on
ultivariable analysis may be due to the low overall mortality
ate (0.65%, less than half the overall stroke rate), which
educed the power to detect a statistically significant difference
n mortality risk across BMI categories.
The paradoxical relationship between obesity and the
isk of postoperative stroke and death may be attributable
o the actions of endocrine factors released from adipose
issue. Adipose tissue, in addition to its role in energy
torage, functions as an endocrine organ, influencing a
ange of metabolic and inflammatory processes through the
ecretion of factors collectively known as adipokines. In
articular, the adipokine adiponectin has been linked to the
besity paradox. Elevated BMI is associated with decreased
evels of adiponectin, and decreased adiponectin levels are
ssociated with incident cardiovascular disease and mortal-
ty in healthy patients.15,16 Paradoxically, however, de-
reased adiponectin levels are associated with reduced risk
f cardiovascular mortality after stroke,17 heart failure,18
nd coronary events.19 Furthermore, a recent prospective
ohort study found that, although obesity was associated
ith prolonged survival after CABG, adjustment for adi-
onectin levels abolished this effect.20 This suggests that
diponectin could mediate the paradoxical association be-
ween obesity and postoperative mortality and stroke.
In contrast to the U-shaped pattern seen with stroke
nd mortality, increasing BMI was associated with incre-
ental increases in the incidence of cardiac arrest, and there
as a strong trend toward increased adjusted risk of cardiac
rrest in class III obese patients. Obesity is a risk factor for
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Volume 55, Number 5 Jackson et al 1311coronary artery disease21 and is also independently associ-
ated with cardiac atrial and ventricular dysfunction.22
These factors probably underlie the association of severe
obesity with postoperative cardiac arrest.
Classes II and III obesity were each associated with a
significant, or nearly significant, twofold increase in the risk
of postoperative SSI. The association of obesity with in-
creased risk of SSI has been recognized after multiple
vascular surgery procedures.7,8,23-26 Although not a com-
mon complication after CEA, the finding of increased risk
of SSI does highlight the importance of preventive mea-
sures, such as weight-based dosing of prophylactic antibi-
otics and prompt surgical drain removal, especially in obese
patients.
The major strength of this study was the use of the ACS
NSQIP database, which provided a large sample size for
analysis. Furthermore, ACS NSQIP data are prospectively
collected using standard definitions, helping to minimize
reporting bias. There are, however, limitations to this study
due to the use of administrative data. The ACS NSQIP
defines diabetes and hypertension by use of medication to
treat these conditions; as a result, it was not possible to
control for patients with untreated diabetes or hyperten-
sion. It is likely, however, that the majority of patients with
these diagnoses were pharmacologically treated for these
conditions perioperatively, in order to optimize postoper-
ative management. Furthermore, it was not possible to
account for variables that are not included in the ACS
NSQIP, including medication use, type of hospital, hospi-
tal or surgeon case volume, bilateral repair, or repair tech-
nique. Inability to adjust for these variables may have
Table V. Multivariable analysis of secondary outcomes
Myocard
OR
BMI category
Underweight 1.01 (0
Normal weight Re
Overweight 1.21 (0
Class I obese 0.72 (0
Class II obese 0.58 (0
Class III obese 0.59 (0
Age, 5-year increase 1.26 (1
ASA class
3
4-5
Angina 2.95 (1
Dyspnea on exertion 1.66 (1
Dialysis 3.31 (1
Preoperative wound infection
Systemic inflammatory response syndrome/sepsis 4.86 (1
Functional status partially dependent
ASA, American Society of Anesthesiology; BMI, body mass index; CI, confi
OR (95% CI) associated with BMI classes and statistically significant variabl
aOR not estimable in multivariable model.
bP  .05.
cP  .001.
dP  .01.influenced study results. Additionally, this analysis was lim-ted to the use of BMI as the measurement of obesity, and
t is possible that use of an alternative scale would alter the
elationship between obesity and postoperative outcomes.
inally, the ACS NSQIP database does not discriminate
etween symptomatic and asymptomatic carotid occlusive
isease. It is possible that carotid plaque morphology and
he risk of embolism differs across the BMI classes.
Although obesity is associated with the development of
arotid artery disease, class I obesity is associated with
ecreased risk of stroke after CEA. Furthermore, this anal-
sis found no evidence of elevated perioperative mortality
isk among obese patients after CEA. These findings sug-
est that surgeons may safely undertake CEA in obese
atients, when indicated.
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